SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 230 filers reported holding SAGE THERAPEUTICS INC in Q4 2017. The put-call ratio across all filers is 0.96 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $29,895,000 | -49.9% | 414,122 | -2.7% | 0.11% | -53.7% |
| Q3 2019 | $59,715,000 | -23.3% | 425,656 | +0.2% | 0.25% | -21.2% |
| Q2 2019 | $77,807,000 | +13.6% | 424,964 | -1.3% | 0.31% | +7.6% |
| Q1 2019 | $68,482,000 | +109.5% | 430,570 | +26.2% | 0.29% | +75.8% |
| Q4 2018 | $32,694,000 | -28.0% | 341,309 | +6.1% | 0.16% | -12.2% |
| Q3 2018 | $45,425,000 | +7.7% | 321,596 | +19.3% | 0.19% | +2.2% |
| Q2 2018 | $42,192,000 | +42.9% | 269,543 | +47.1% | 0.18% | +35.3% |
| Q1 2018 | $29,518,000 | +103.4% | 183,263 | +108.0% | 0.14% | +103.0% |
| Q4 2017 | $14,515,000 | +149.3% | 88,123 | -5.7% | 0.07% | +139.3% |
| Q3 2017 | $5,822,000 | -10.9% | 93,458 | +13.9% | 0.03% | -15.2% |
| Q2 2017 | $6,532,000 | +18.6% | 82,024 | +5.8% | 0.03% | +13.8% |
| Q1 2017 | $5,509,000 | +22.2% | 77,510 | -12.2% | 0.03% | +16.0% |
| Q4 2016 | $4,510,000 | +33.6% | 88,320 | +20.4% | 0.02% | +38.9% |
| Q3 2016 | $3,377,000 | +139.2% | 73,331 | +56.4% | 0.02% | +125.0% |
| Q2 2016 | $1,412,000 | +588.8% | 46,876 | +632.0% | 0.01% | +700.0% |
| Q1 2016 | $205,000 | -45.0% | 6,404 | 0.0% | 0.00% | -50.0% |
| Q4 2015 | $373,000 | -34.7% | 6,404 | -52.6% | 0.00% | -33.3% |
| Q3 2015 | $571,000 | +4.4% | 13,500 | +80.0% | 0.00% | +50.0% |
| Q2 2015 | $547,000 | – | 7,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,966,688 | $120,204,000 | 10.81% |
| Integral Health Asset Management, LLC | 230,000 | $14,058,000 | 4.30% |
| Asymmetry Capital Management, L.P. | 102,462 | $6,262,000 | 4.02% |
| ACUTA CAPITAL PARTNERS, LLC | 225,000 | $13,752,000 | 3.74% |
| DAFNA Capital Management LLC | 158,306 | $9,676,000 | 3.14% |
| Bain Capital Life Sciences Investors, LLC | 499,100 | $30,505,000 | 2.84% |
| Boxer Capital, LLC | 1,094,000 | $66,865,000 | 2.31% |
| Palo Alto Investors LP | 590,200 | $36,073,000 | 1.98% |
| Logos Global Management LP | 250,000 | $15,280,000 | 1.96% |
| Bellevue Group AG | 1,579,504 | $96,539,000 | 1.33% |